TY  - CONF

T1  - Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy.

JO  - CLINICAL CANCER RESEARCH

UR  - http://eprints.whiterose.ac.uk/131051/

PY  - 2017/12/01

AU  - Mueller LME

AU  - Parrish C

AU  - Migneco G

AU  - Scott GB

AU  - Holmes M

AU  - Melcher AA

AU  - Lawson MA

AU  - Cook G

AU  - Errington-Mais F

ED  - 

VL  - 23

IS  - 24

SP  - 44

EP  - 44

Y2  - 2024/12/22

ER  -